BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 31466586)

  • 1. Cutaneous T Cell Lymphoma: A Difficult Diagnosis Demystified.
    Peterson E; Weed J; Lo Sicco K; Latkowski JA
    Dermatol Clin; 2019 Oct; 37(4):455-469. PubMed ID: 31466586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of cutaneous T-cell lymphomas: Established and emergent therapies.
    Wain T; Venning VL; Consuegra G; Fernandez-Peñas P; Wells J
    Australas J Dermatol; 2019 Aug; 60(3):200-208. PubMed ID: 30809800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Malignant lymphoma of the skin].
    Burg G; Dommann S; Dummer R
    Ther Umsch; 1993 Dec; 50(12):828-34. PubMed ID: 8171405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
    Edelson RL
    Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining early mycosis fungoides: validation of a diagnostic algorithm proposed by the International Society for Cutaneous Lymphomas.
    Vandergriff T; Nezafati KA; Susa J; Karai L; Sanguinetti A; Hynan LS; Ambruzs JM; Oliver DH; Pandya AG
    J Cutan Pathol; 2015 May; 42(5):318-28. PubMed ID: 25721994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous T cell lymphoma: update on treatment.
    Wollina U
    Int J Dermatol; 2012 Sep; 51(9):1019-36. PubMed ID: 22909354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell receptor-gamma gene analysis in evolving to advancing cutaneous T-cell lymphoma.
    Foo CC; Tang MB; Chong TK; Sun YJ; Tan SH
    Australas J Dermatol; 2007 Aug; 48(3):156-60. PubMed ID: 17680965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multidisciplinary approach to the diagnosis of cutaneous T-cell lymphomas.
    Payne CM; Grogan TM; Spier CM; Bjore CG; Richter LC; Cromey DW; Rangel CS
    Ultrastruct Pathol; 1992; 16(1-2):99-125. PubMed ID: 1557836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New perspectives in experimental and clinical research for cutaneous T cell lymphomas.
    Burg G; Häffner A; Böni R; Dommann S; Dummer R
    Recent Results Cancer Res; 1995; 139():225-37. PubMed ID: 7597294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous T-cell lymphomas with pathogenic somatic mutations and absence of detectable clonal T-cell receptor gene rearrangement: two case reports.
    Rojansky R; Fernandez-Pol S; Wang E; Rieger KE; Novoa RA; Zehnder JL; Kunder CA; Kim YH; Khodadoust MS; Brown RA
    Diagn Pathol; 2020 Sep; 15(1):122. PubMed ID: 32988392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staging and management of cutaneous T-cell lymphoma.
    Scarisbrick JJ
    Clin Exp Dermatol; 2006 Mar; 31(2):181-6. PubMed ID: 16487086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cutaneous T-cell lymphoma].
    Dippel E; Gellrich S; Klemke CD; Goerdt S; Sterry W
    J Dtsch Dermatol Ges; 2003 Dec; 1(12):965-80; quiz 981-2. PubMed ID: 16285650
    [No Abstract]   [Full Text] [Related]  

  • 14. Histopathology and genetics of cutaneous T-cell lymphoma.
    Smoller BR; Santucci M; Wood GS; Whittaker SJ
    Hematol Oncol Clin North Am; 2003 Dec; 17(6):1277-311. PubMed ID: 14710885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duration of symptoms does not correlate with results of T-cell gene rearrangement studies in patients evaluated for cutaneous T-cell lymphoma.
    Larson AR; Rodig S; Granter SR
    J Cutan Pathol; 2015 Sep; 42(9):618-21. PubMed ID: 25931314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous T-cell lymphomas (including rare subtypes). Current concepts. II.
    Paulli M; Berti E
    Haematologica; 2004 Nov; 89(11):1372-88. PubMed ID: 15531460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics of Cutaneous T Cell Lymphoma: From Bench to Bedside.
    Damsky WE; Choi J
    Curr Treat Options Oncol; 2016 Jul; 17(7):33. PubMed ID: 27262707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of clonal T cells to the epidermis in cutaneous T-cell lymphoma.
    Fivenson DP; Hanson CA; Nickoloff BJ
    J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):717-23. PubMed ID: 7929915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring the decrease of circulating malignant T cells in cutaneous T-cell lymphoma during photopheresis and interferon therapy.
    Ferenczi K; Yawalkar N; Jones D; Kupper TS
    Arch Dermatol; 2003 Jul; 139(7):909-13. PubMed ID: 12873887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controversies in the management of the cutaneous T cell lymphomas.
    Zic JA
    Dermatol Ther; 2009; 22(5):407-17. PubMed ID: 19845718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.